中国科技论文统计源期刊 中文核心期刊  
美国《化学文摘》《国际药学文摘》
《乌利希期刊指南》
WHO《西太平洋地区医学索引》来源期刊  
日本科学技术振兴机构数据库(JST)
第七届湖北十大名刊提名奖  
医药导报, 2017, 36(4): 396-399
doi: 10.3870/j.issn.1004-0781.2017.04.009
脑卒中二级预防中的实践及评价*
Practice and Evaluation of Extended Clinical Pharmacy Service in the Secondary Prevention of Stroke
兰鸿1,, 左金梅2,, 陶平德1, 陈鸿梅2

摘要:

目的 评价临床药学延伸服务在脑卒中二级预防中的应用效果。方法 选择湖北省十堰市太和医院2013年6月—2014年8月住院治疗的脑卒中患者,将符合纳入标准的患者配对并依次编号,用随机的方法分为观察组(n=100)和对照组(n=102)。两组患者住院治疗期间按疾病临床路径进行护理,由临床药师行药物宣教。对照组出院后1个月实施电话随访,指导遵医行为。观察组执行临床药师主导的延续服务方案。比较两组患者出院后3,6和12个月的服药依从性(Morisky量表)、收缩压(SBP)、舒张压(DBP)、糖化血红蛋白( HbA1C)、血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和复发率的差异。结果 两组患者出院后3个月,服药依从性、SBP、 DBP、HbA1C、TC和LDL-C差异无统计学意义(P>0.05),但SBP、 DBP、HbA1C、TC和LDL-C水平均低于入组时(P<0.05或P<0.01);两组患者出院后6和12个月服药依从性、SBP、 DBP、HbA1C、TC和LDL-C差异有统计学意义(P<0.05或P<0.01)。出院后3,6和12个月复发率为2.00%,5.00%和15.00%;对照组复发率为2.94%,13.72%和28.43%。结论 临床药学延伸服务在脑卒中患者二级预防中可提高患者用药的依从性,更好控制血压、血糖和血脂水平,降低复发率,值得在临床实践工作中推荐。

关键词: 临床药学 ; 脑卒中 ; 二级预防 ; 延续服务

Abstract:

Objective To evaluate the application effect of clinical pharmacy services in the secondary prevention of stroke. Methods Hospitalized stroke patients were selected in Taihe Hospital from June 2013 to August 2014. The patients meeting the inclusion criteria were paired and sequentially numbered, and randomly divided into observation group (n=100) and control group (n=102). The patients were treated routinely during the hospitalization. The clinical pharmacists conducted the drug education. The control group implemented the telephone follow-up for guiding compliance behavior one month after discharge. The observation group continued to perform clinical pharmacist-leading service projects. The medication compliance (Morisky scale), systolic blood pressure (SBP), diastolic blood pressure (DBP), glycated hemoglobin (HbA1C), serum total cholesterol (TC), low density lipoprotein-C (LDL-C) and relapse rate were compared three months, six months and twelve months after the two groups discharged. Results The medication compliance, SBP, DBP, HbA1C, TC, LDL-C and recurrence rate after hospital discharge were no statistically significant (P>0.05) three months after the two groups discharged, but statistically significant between the two groups (P<0.05 or P<0.01) six months and twelve months after the two groups discharged. Levels of SBP, DBP, HbA1C, TC and LDL-C in the two groups were both significantly lower than before (P<0.05 or P<0.01). The relapse rate of the observation group three months, six months and twelve months after they discharged was 2.00%, 5.00% and 15.00%, respectively, and that of the control group was 2.94%, 13.72% and 28.43%, respectively. Conclusion The pharmacy services in the secondary prevention of stroke can improve the patient medication compliance and better control the blood pressure, blood glucose and blood lipid levels, and reduce the relapse rate. It should be recommended in the clinical practice work.

Key words: Clinical pharmacy ; Stroke ; Secondary prevention ; Continuation of the service

脑卒中是神经系统常见病和多发病,具有发病率高、致残率高、复发率高的特点,是当今世界严重危害中老年人生命与健康的最主要疾病之一。目前我国现有脑卒中患者700多万例,这个庞大的群体是脑卒中二级预防的重点对象[1]。二级预防主要目的是通过药物治疗控制脑卒中的危险因素,降低脑卒中复发。药物治疗主要包括抗血小板聚集、调脂药(主要是他汀类)以及必要的降压、降糖药物。在二级预防中,患者用药的依从性起关键作用,如果没有患者的依从性做保障,任何正确有效的预防措施都无法实施[1-2]。2013年6月—2015年8月,我院临床药师参与脑卒中患者二级预防的实践,取得满意的效果,现报道如下。

1 资料与方法
1.1 临床资料

选择湖北医药学院附属太和医院2013年6月—2014年8月住院治疗的脑卒中患者。入选标准:①患者均经头颅MRI/CT检查证实,诊断符合中国脑卒中诊治指南标准(根据脑血管病病史、临床症状、神经系统检查、结合神经影像学结果作出诊断);②患者年龄50~65岁,初次发病,神志清楚,入院时Barthel指数评分>20分;③患者住院期间收缩压(SBP)≥140 mmHg(1 mmHg=0.133 kPa)和舒张压(DBP)≥90 mmHg;糖化血红蛋白(HbA1C) ≥7.0%;总胆固醇(TC)>5.17 mmol·L-1,低密度脂蛋白胆固醇(LDL-C)>3.37 mmol·L-1,既往未规范服用降压药、降糖药和调脂药;④出院后返家,且家庭住址在主城区范围内;⑤小学及以上文化,能够接收并且阅读手机短信,自愿参加研究[3-4]。排除标准: ①住院时间< 1 周的病例;②伴有其他危重疾病,如心功能衰竭、呼吸功能衰竭、肾功能衰竭、肝功能衰竭、恶性肿瘤;③意识不清或患有精神心理疾病、失语症和失聪,无法进行有效沟通的患者;④未完成全部数据收集和自愿退出研究的病例。根据样本采集方法,将218例患者进行配对处理分组,首先将条件相近的患者配对并依次编号,再用随机(利用计算机程序能产生随机数,偶数为对照组,奇数为观察组)的方法将各对观察对象分配到两组研究中[5]。在研究中观察组失访9例,对照组失访7例,最终观察组100例和对照组102例进入统计分析。两组患者年龄、性别、受教育年限、脑卒中类型、Barthel指数评分等一般资料比较,差异无统计学意义(P>0.05)。见表1。

1.2 住院期间健康教育

两组患者入院后均建立健康档案,记录患者的姓名、地址、联系电话等;住院治疗期间按疾病临床路径进行护理;发放《脑卒中健康教育手册》(参照指南 [6-8]编写);要求患者参加医院每2周一次的《脑卒中防治知识大讲堂》专题循环讲座的学习。两组患者均以指南推荐给予以控制颅压、改善脑循环、调控血压和血糖、抗血小板聚集、降脂等治疗。临床药师根据患者入院后服药情况,为每例患者定制一张独特的用药宣教单,进行一对一用药教育。内容包括为什么要服用这个药物(药物的适应证及药理作用)、如何服用(用法用量)、是否可以和其他药物一起服用、服用期间还有什么要特别注意的事项(药物副作用)等。在医院信息系统中嵌入出院带药系统,由临床药师进行审核并提供专业的出院带药指导单。出院时护士再次行健康行为(饮食、生活起居、功能锻炼、运动、血压监测、定期复诊等)指导,要求患者出院后3,6,12个月复诊。在复诊时进行相关量表和指标评价。对照组出院后1个月内护士进行1次专病电话回访,指导出院后的遵医行为。

1.3 观察组在此基础上行延续服务

延续服务方案为:①由临床药师、神经科主管护师、神经科医生、康复治疗师组成延续服务团队。②患者出院时携带由临床药师设计的一个32开26页的《用药记录册》,记录患者每周用药的依从性自我评价和血压监测值。③出院后第1周进行电话随访,预约家庭访视时间(必须在出院后4周内),访视主要内容为督促和检查患者用药的依从性。④建立用药知识短信库,其内容包括每类药物的介绍、服用每种药物的注意事项、用药依从性的好处等。根据家庭访视情况为患者制定个性化用药指导短信,发送至患者手机上。

1.4 评价指标

1.4.1 一般资料采集整理 收集患者姓名、性别、年龄、职业、文化程度、高血压病史、糖尿病病史、药物治疗情况等。患者入组时收缩压、舒张压的数据取住院第1,2天平静状态下血压平均值,出院后收缩压、舒张压的数据取监测的均值。

1.4.2 生化指标测定 患者入组时血糖数据取住院第1,2天三餐前空腹血糖平均值。HbA1C、TC和LDL-C的含量由生化分析仪测定。

1.4.3 用药依从性评定 采用Morisky量表,该量表为8个条目,分值在0~8分,总分为8分时为高依从性,6≤总分<8 分为中依从性,低于6分低依从性,得分愈高,表示依从性愈好[9]

1. 5 统计学方法

采用SPSS 17.0版统计软件包进行统计学分析。计数资料以率/百分比表示,组间比较采用χ2检验,计量资料以均数±标准差( ヌ±s)表示,组间比较采用t检验。以P<0.05为差异有统计学意义。

表1 两组患者一般资料比较
Tab.1 Comparison of the baseline data between two groups of patients ヌ±s
组别 例数 年龄/岁 性别 受教育年限 脑卒中类型 Barthel
评分
SBP DBP HbA1C/
%
TC LDL-C
≤9年 >9年 脑出血 脑梗死
mmHg (mmol·L-1)
% % % % % %
对照组 102 64.21±10.98 67 65.69 35 34.31 35 34.31 67 65.69 28 27.45 74 72.55 34.70±9.60 151.55±14.10 94.75±13.50 7.94±1.68 5.69±0.98 4.12±0.67
观察组 100 63.28±9.64 65 65.00 35 35.00 36 36.00 64 64.00 28 28.00 72 72.00 30.20±6.50 153.85±13.65 95.65±11.10 8.13±1.36 5.78±0.82 4.08±0.74
t或χ2 0.140 0.008 0.045 0.005 1.011 0.583 0.288 0.056 0.058 0.087
P >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05

表1 两组患者一般资料比较

Tab.1 Comparison of the baseline data between two groups of patients ヌ±s

2 结果
2.1 两组患者用药依从性、血压、糖化血红蛋白及血脂情况

两组患者出院后3个月,服药依从性、SBP、 DBP、HbA1C、TC和LDL-C差异无统计学意义(P>0.05),但SBP、 DBP、HbA1C、TC和LDL-C水平均低于入组时(P<0.01);两组患者出院后6和12个月的服药依从性、SBP、 DBP、HbA1C、TC和LDL-C差异有统计学意义(P<0.05或P<0.01)。见表2。

表2 两组患者用药依从性、血压、糖化血红蛋白和血脂比较
Tab.2 Comparison of medication compliance, blood pressure, glycosylated hemoglobin and blood lipid between two groups of patients ヌ±s
组别 例数 服药依从性
评分
SBP DBP HbA1C
/%
TC LDL-C
mmHg (mmol·L-1)
对照组 102
入组时 - 151.55±14.10 94.75±13.50 7.94±1.68 5.69±0.98 4.12±0.67
出院后3个月 6.88±1.38 118.50±17.35*1 90.60±9.25*2 6.70±0.53*2 4.92±0.73*2 2.84±0.79*1
出院后6个月 4.98±1.45 125.80±17.10*1 91.20±8.35*2 7.31±0.64*2 4.78±1.04*2 3.92±0.61*2
出院后12个月 4.87±1.94 138.60±17.50*2 92.30±9.75 7.72±0.67 5.13±0.82 3.14±0.66*2
观察组 100
入组时 - 153.85±13.65 95.65±11.10 8.13±1.36 5.78±0.82 4.08±0.74
出院后3个月 7.08±0.64 120.20±15.80*1 89.80±8.65*2 6.62±0.44*2 5.08±0.75*3 2.76±0.52*2
出院后6个月 6.76±1.32*3 116.30±16.90*1*4 84.10±7.35*1*4 6.36±0.83*1*4 4.29±0.58*1 *4 2.20±0.55*1 *4
出院后12个月 6.18±1.28*4 117.40±16.30*1*3 84.30±9.60*1*4 6.87±0.35*2*3 4.36±0.69*2 *3 2.27±0.63*1 *4

Compared with the same group at the enrollment,*1P<0.01, *2P<0.05;compared with control group, *3P<0.01,*4P<0.05

与本组入组时比较,*1P<0.01,*2P<0.05;与对照组比较,*3P<0.01,*4P<0.05

表2 两组患者用药依从性、血压、糖化血红蛋白和血脂比较

Tab.2 Comparison of medication compliance, blood pressure, glycosylated hemoglobin and blood lipid between two groups of patients ヌ±s

2.2 两组患者出院后3,6,12个月复发率情况

复发定义为脑卒中后,又发生新的中枢神经系统损伤的定位体征或原有症状加重,并有头颅CT或MRI资料证实。统计时例数为累加人次。出院后3个月两组患者复发率差异无统计学意义(P>0.05);出院后6和12个月的观察组复发率为5.00%和15.00%(5和15例);对照组复发率为13.72%和28.43%(14和29例),差异有统计学意义(P<0.05)。

3 讨论
3.1 临床药学延伸服务对脑卒中患者服药依从性的影响

目前在我国的医疗实践中,患者的出院用药通常由医师在出院记录单上描述用法及剂量,护士遵照医嘱取回药后,在药盒上注明服药次数及服药剂量,交给患者或家属,并进行简单用药指导。很多患者不能理解遵医嘱长期用药在脑卒中二级预防中的意义。随着医院药学服务的广泛开展,临床药师提供全方位、高质量的药学服务将成为医院药学工作的主要内容。美国的59%的医院设立由医师、药师、护士等组成的患者教育委员会。美国的临床药师贯彻“一切以患者为中心”的药学服务理念,从入院到出院的不同阶段对患者进行用药教育,通过各种途径增强患者的用药依从性和随访依从性 [10]

马锐华等 [11]对缺血性脑卒中患者出院后3个月的调查中发现:59.4%未再接受指南推荐的降压药治疗,52.6%未接受他汀类药物的治疗。本研究中两组患者出院后3个月服药依从性评分为7.18±1.24和6.88±1.38,表明用药依从性好,在患者出院后3个月降压、降糖、抗血小板聚集、降脂药的依从性分别为91.82%,89.32%,93.48%和81.25%,高于马锐华等的调查研究。分析主要原因为:①本研究中组成了由临床药师主导的药师、医师、护士共同为患者进行药物知识和疾病知识宣教,提高患者对疾病和药物治疗的理解和重视程度;②医院内的健康教育不同程度地约束和提高患者的用药依从性;③出院后1个月的专病电话随访和家庭访视提高患者用药依从性。BUSHNELL等 [12]

对缺血性脑卒中患者出院后12个月的随访发现,用药依从性差者占34.1%。本研究中出院后6和12个月治疗组服药依从性评分为6.76±1.32和6.18±1.28;对照组服药依从性评分为4.98±1.45和4.87±1.94;观察组用药依从性差者为21.26%和28.58%;对照组用药依从性差者为38.46%和41.63%。两组患者用药依从性差异有统计学意义,分析主要原因为:对照组患者随着出院时间延长及干预措施减弱,服药依从性降低。观察组患者通过家庭访视、定期个体化的用药短信发送等延伸服务,不但向患者传递正确的服药知识,增强其遵医行为,提高了患者用药的依从性。

3.2 临床药学延伸服务对脑卒中患者复发率的影响

脑卒中具有复发率高的特点,不健康生活方式以及高血压、高血糖、高血脂等都与复发密切相关[13-14]。脑卒中预防指南中指出:一般高血压患者应将血压控制在140/90 mmHg以下,收缩压每升高 10 mmHg,脑卒中发生危险增加49%;舒张压每升高5 mmHg,脑卒中发生危险增加46%;高血压并发糖尿病患者HbA1C<7%时,脑卒中风险降低33%;血脂异常并发高血压、糖尿病患者要使LDL-C水平比基线下降30%~40%可以预防复发[14]。在表2中,两组患者出院后3个月SBP、DBP、HbA1C、TC、LDL-C和用药依从性无差异,但SBP、DBP、HbA1C、TC和LDL-C明显低于入院时,说明遵医行为可以有效控制血压、血糖和血脂水平,防治脑卒中复发。观察组患者出院后6和12个月复发率为5.00%和13.75%,对照组复发率为15.00%和28.43%,观察组的复发率低于对照组。MA等[15]指出中国脑卒中复发率高于西方国家,主要是因为中国脑卒中患者用药依从性较差。在表2中可以看出观察组出院后6和12个月用药依从性、血压、糖化血红蛋白和血脂控制优于对照组,因此观察组脑卒中的复发率低于对照组。

综上所述,临床药学延伸服务可以帮助脑卒中患者正确认识和安全使用药物,提高患者用药依从性,更好地控制血压、血糖和血脂水平,降低脑卒中的复发。临床药师在脑卒中的二级预防中患者治疗过程中发挥积极重要的作用,成为医疗团队中不可或缺的重要成员之一。这种工作模式值得在临床实践工作中推荐。后续研究将进一步扩大样本量,并进行其他实验室指标的随访评估,以期为临床提供更有价值的实证依据。

The authors have declared that no competing interests exist.

参考文献

[1] 韩芳,李双,曹克刚.关于2014年美国脑卒中和短暂性脑缺血发作二级预防指南更新的解读与思考[J].中西医结合心脑血管病杂志,2015,14(1):28-32.
2014年,美国心脏协会(AHA)/美国卒中协会(ASA)发布了最新的脑卒中和短暂性脑缺血发作(TIA)的二级预防指南,是继2011年之后的再次更新和总结。本文就2014年指南中的一些主要更新内容进行解读与思考。
[本文引用:2]
[2] 万志荣,何向楠,李继来,.缺血性脑卒中患者二级预防用药依从性的现状研究[J].中国医药指南,2014,12(4):1-3.
目的:调查我医院缺血性脑卒中(ischemic stroke,IS)患者二级预防用药依从性的现状及影响因素。方法采用访谈形式,收集因IS在我院住院的患者出院1年来二级预防用药情况。结果81例我 院IS患者中,抗血小板聚集、降脂药的依从性分别为72.8%、49.3%,合并高血压、糖尿病患者降压、降糖药依从性分别为77.6%、70.6%。结 论 IS患者二级预防中抗血小板、降脂、降压、降糖药物的应用都未达标,其中降脂药依从性依从性最差。医疗付费方式是影响我院IS患者依从性的独立危险因素。
URL    
[本文引用:1]
[3] 中华医学会神经病学分会脑血管病学组、急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
篇首:
[本文引用:1]
[4] 中华医学会神经病学分会脑血管病学组.中国脑出血诊治指南2014[J].中华神经科杂志,2015,48(6): 435-444.
@@
[本文引用:1]
[5] LARSSON B W,LARSSON G.Patients views on quality of care: do they merely reflect their sense of coherence?[J].J Adv Nurs,1999,30(1):33-39.
The aim was to explore the relationship between patients' perceptions of the quality of care and their sense of coherence. The sample consisted of 782 Swedish in-patients at a gynaecological, a medical, an orthopaedic, and a surgical department. The median age was 59 years and 55% of the patients were women. Data were collected using the Quality from the Patient's Perspective (QPP) Questionnaire and the Sense of Coherence Questionnaire. The QPP consists of 61 items designed to measure the following four quality dimensions: the medical-technical competence and the degree of identity-orientation in the actions of the caregivers, the physical-technical conditions and the socio-cultural atmosphere of the care organization. Each question is posed in two different ways in the QPP; one measures perceived reality of the item in question and one the subjective importance the patient ascribes to it. Results showed that patients' ratings of perceived reality covaried systematically with their sense of coherence. This was particularly the case on questions rated by experts to be more abstract and emotionally loaded. Patients' ratings of the subjective importance of the items were weakly related to their sense of coherence. The results are discussed in terms of negative affectivity and culturally shared ideals regarding quality of care.
DOI:10.1046/j.1365-2648.1999.01046.x      PMID:10403978      URL    
[本文引用:1]
[6] 中华医学会神经病学分会神经康复学组.中国脑卒中康复治疗指南(2011完全版)[J].中国康复理论与实践,2012,18(4):301-316.
正前言脑卒中具有高发病率、高致残率的特点。中国每年新发脑卒中患者约200万人,其中70%~80%的脑卒中患者因为残疾不能独立生活[1]。循证医学证实,脑卒中康复是降低致残率最有效的方法,也是脑卒中组织化管理模式中不可或缺的关键环节[2]。现代康复理论和实践证明,有效的康复训练能够减轻患
[本文引用:0]
[7] 张晓丹,王姝梅,秦伟,.2011年美国心脏协会/美国卒中协会脑卒中一级预防指南解读[J].山东医药,2011,51(20):3-5.
脑卒中的一级预防是指通过早期改变不健康的生活方式,积极主动地控制各种危险因素,从而达到使脑卒中不发生或推迟发病的目的。从流行病学角度看,只有一级预防才能降低疾病的人群发病率^[1]。2010年12月美国心脏协会(AHA)/美国卒中协会(ASA)撰写委员会在(Stroke))杂志上公布的关于脑卒中一级预防指南推荐的更新意见,
[本文引用:0]
[8] 中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010,43(2):154-160.
目前脑血管病已成为我国城市和农村人口的第一位致残和死亡原因,且发病有逐年增多的趋势.流行病学研究表明,中国每年有150万~200万新发脑卒中的病例,校正年龄后的年脑卒中发病率为(116~219)/10万人口,年脑卒中死亡率为(58~142)/10万人口.
[本文引用:0]
[9] MORISKY D E,KROUSEL-WOOD M,WARD H J.Predictive validity of a medication adherence measure in an outpatient setting[J].J Clin Hypertens (Greenwich),2008,10(5):348-354.
This study examines the psychometric properties and tests the concurrent and predictive validity of a structured, self-reported medication adherence measure in patients with hypertension. The authors also assessed various psychosocial determinants of adherence, such as knowledge, social support, satisfaction with care, and complexity of the medical regimen. A total of 1367 patients participated in the study; mean age was 52.5 years, 40.8% were male, 76.5% were black, 50.8% graduated from high school, 26% were married, and 54.1% had income <$5,000. The 8-item medication adherence scale was reliable (alpha=.83) and significantly associated with blood pressure control (P<.05). Using a cutpoint of <6, the sensitivity of the measure to identify patients with poor blood pressure control was estimated to be 93%, and the specificity was 53%. The medication adherence measure proved to be reliable, with good concurrent and predictive validity in primarily low-income, minority patients with hypertension and might function as a screening tool in outpatient settings with other patient groups.
DOI:10.1111/j.1751-7176.2008.07572.x      PMID:18453793      URL    
[本文引用:1]
[10] 徐萍. 中美临床药师的培养及工作模式差异探讨[J].中国医院,2015,19(10):48-50.
为提升我国临床药师服务质量和能力,以美国伊利诺伊州大学芝加哥校区药学院为研究对象,对美国的药学教育和临床药师培养与工作模式进行研究,结合我国临床药学发展现状进行对比分析和论述,认为美国药学教育准入严格、临床药师的培养注重临床实践以及高度成熟规范的临床药师工作模式值得借鉴.
[本文引用:1]
[11] 马锐华,王拥军,王春雪,.脑梗死/短暂性脑缺血发作住院患者二级预防依从性研究及90天随访[J].中华医学杂志,2008,88(37):2618-2622.
目的 了解北京住院脑梗死/短暂性脑缺血发作(TIA)患者对于住院期间及出院90 d二级预防药物及行为修正的依从性现状.方法 调查2006年10月1日至2007年5月1日参加研究医院的符合入组标准的连续住院脑梗死及TIA患者对于肾素-血管紧张素转换酶抑制剂(ACEI)/ 血管紧张素Ⅱ受体拮抗剂(ARB)、他汀药物、抗血小板药物治疗的使用率,戒烟、控制体重等行为修正率并随访90 d.结果 入组患者中使用抗血小板及他汀等药物及行为修正率偏低,并且在出院90 d这一比例进一步降低.结论 医生应关注患者有明确循证医学依据的二级预防药物及行为修正的依从性,并采取行之有效的措施提高患者药物治疗及行为修正的依从性.
[本文引用:1]
[12] BUSHNELL C D,OLSON D M,ZHAO X,et al.Secondary preventive medieation persistenee and adherenee 1year after stroke[J].Neurology,2011,77(12):1182-1190.
ABSTRACT Data on long-term use of secondary prevention medications following stroke are limited. The Adherence eValuation After Ischemic stroke-Longitudinal (AVAIL) Registry assessed patient, provider, and system-level factors influencing continuation of prevention medications for 1 year following stroke hospitalization discharge. Patients with ischemic stroke or TIA discharged from 106 hospitals participating in the American Heart Association Get With The Guidelines-Stroke program were surveyed to determine their use of warfarin, antiplatelet, antihypertensive, lipid-lowering, and diabetes medications from discharge to 12 months. Reasons for stopping medications were ascertained. Persistence was defined as continuation of all secondary preventive medications prescribed at hospital discharge, and adherence as continuation of prescribed medications except those stopped according to health care provider instructions. Of the 2,880 patients enrolled in AVAIL, 88.4% (2,457 patients) completed 1-year interviews. Of these, 65.9% were regimen persistent and 86.6% were regimen adherent. Independent predictors of 1-year medication persistence included fewer medications prescribed at discharge, having an adequate income, having an appointment with a primary care provider, and greater understanding of why medications were prescribed and their side effects. Independent predictors of adherence were similar to those for persistence. Although up to one-third of stroke patients discontinued one or more secondary prevention medications within 1 year of hospital discharge, self-discontinuation of these medications is uncommon. Several potentially modifiable patient, provider, and system-level factors associated with persistence and adherence may be targets for future interventions.
DOI:10.1212/WNL.0b013e31822f0423      PMID:3265047      URL    
[本文引用:1]
[13] 刘建平,解瑞谦,程锦泉,.中国居民吸烟、饮酒等行为因素与脑卒中的关系[J].中国行为医学科学,2005,14(7):613-615.
目的探讨吸烟、饮酒等行为因素与脑卒中的关系。方法应用Meta分析对有关研究吸烟、饮酒等行为因素与脑卒中关系的文献进行综合定量分析。结果在检索并纳入的23篇有关研究吸烟、饮酒等行为因素与脑卒中关系的文章中,吸烟、饮酒、体育活动、被动吸烟与脑卒中关系的合并OR值分别是1.86(95%CI:1.62~2.13)、1.84(95%CI:1.71~1.97),0.41(95%CI:0.08~2.10),3.22(95%CI:2.04~5.07)。按脑卒中类型分层合并分析,结果发现,吸烟与缺血性脑卒中、出血性脑卒中的联系的OR值分别为2.60(95%CI:2.01~3.36)、2.00(95%CI:1.54~2.60)。饮酒与缺血性脑卒中、出血性脑卒中的联系的OR值分别为2.10(1.11~3.97)、2.24(1.62~2.99)。结论吸烟、饮酒、被动吸烟是脑卒中及其各亚型的危险因素。
[本文引用:1]
[14] 医脉通.中国脑卒中一级预防规范[EB/OL].[2015-05-08]..
URL    
[本文引用:2]
[15] MA R,WANG C,ZHAO X,et al.A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack[J].Neurol Res,2008,30(4):383-388.
Abstract Poor compliance with evidence-based medicine guidelines could significantly influence the effect of stroke prevention strategies. The objective of this survey is to evaluate the current status of adherence to secondary prevention guidelines based on evidence-based medicine and related lifestyle modifications, both at hospital discharge and 90 days after discharge for inpatients with atherosclerotic cerebral infarction/transient ischemic attack (TIA) in Beijing. The survey enrolled patients with cerebral infarction/TIA, from seven hospitals in Beijing consecutively from 1 October 2006 to 1 May 2007, and was designed to record detailed information including ACEI/ARB, statins, anti-platelet agent therapy, carotid endarterectomy, angioplasty or stent, smoking and weight control behaviors. Seven hundred and eight cerebral infarction/TIA inpatients had been enrolled over the past 7 months from the year of 2006 to 2007. The proportion of patients with ischemic stroke that have not taken any anti-platelet agents, statins and ACEI/ARB were 0.4, 41.8 and 63.6%, respectively. Twenty-seven percent of the total patients have not followed the instructions on quitting tobacco. Five hundred and eighty-eight patients who are suitable to have drug therapy were followed up 90 day after discharge: 26.9% have not adhered to anti-platelet agents; 52.6% have not been treated by statins, and 59.4% have not had ACEI/ARB to lower blood pressure. Only 66.9% of the smokers have been instructed by clinicians on smoking cessation at the time of discharge. The current status of drug therapy and life modification for secondary prevention on ischemic stroke and TIA in Beijing, China, is still very challenging. Clinicians should pay more attention to the patients' adherence to secondary stroke prevention guidelines, to enhance the effectiveness of stroke prevention through filling the gap between the clinical practice and evidence.
DOI:10.1179/174313208X300404      PMID:18544256      URL    
[本文引用:1]
资源
PDF下载数    
RichHTML 浏览数    
摘要点击数    

分享
导出

相关文章:
关键词(key words)
临床药学
脑卒中
二级预防
延续服务

Clinical pharmacy
Stroke
Secondary prevention
Continuation of the servi...

作者
兰鸿
左金梅
陶平德
陈鸿梅

LAN Hong
ZUO Jinmei
TAO Pingde
CHEN Hongmei